In T2D, mineralocorticoid receptor (MR) overactivation is thought to contribute to CKD progression which can be driven by metabolic, haemodynamic or inflammation and fibrosis factors 1,4,7,8,9.

Medtronic’s MiniMed 780G system has received European CE Mark approval to expand the indications for use by people aged two years and above, during pregnancy, and for those with type 2 ...

Blood apoB and T2D In people with T2D, a high number of particles that carry “bad cholesterol” (called low-density lipoproteins or LDL) — which is measured as “high blood apoB” — .

Between 2006 and 2021, Sweden saw a dramatic rise in early-onset type 2 diabetes (T2D), with the prevalence more than doubling from 0.27% to 0.64% and incidence nearly doubling from 54 to 107 per ...

Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy.

Wearable mobile health technology could help people with Type 2 Diabetes (T2D) to stick to exercise regimes that help them to keep the condition under control, a new study reveals. An ...

Researchers conducted a large-scale epidemiological study to explore the potential health benefits of high muscle strength in preventing type 2 diabetes (T2D) across varying levels of genetic risk ...